Evolving brain edema after focal cerebral ischemia is associated with a post ischemic inflammatory response. Cardinal signs of acute inflammation have been noted in a stroke model featuring focal cerebral ischemia reperfusion. These include 1). infiltration of acute inflammatory cells (mostly polymorphonuclear neutrophils or PMNs); 2). endothelial cell (EC) injury reflected by an increase in vascular permeability; and 3). edema formation. The existence of a post ischemic inflammatory response is further supported by 2 lines of evidence: 1) accumulation of inflammatory mediators including kinins and eicosanoids in the ischemic brain; and 2). expression of cytokines and inducible nitric oxide synthase (iNOS). In this application we propose to further characterize the molecular events of this inflammatory process focusing on nitric oxide (NO) cascade.
the specific aims are: 1. To study iNOS expression and changes in NO synthase (NOS) activity in relation to post ischemic inflammatory reaction and the evolution of brain edema. The hypothesis to be tested is that increase in iNOS expression and NOS activity contribute to post ischemic inflammatory process. Appropriate modulation of NO cascade may reduce the inflammatory reaction and brain edema. 2. To study the cellular mechanism of post ischemic iNOS expression. The hypothesis to be tested is that iNOS expression and NOS activity are enhanced by cell cell interaction (PMN EC, or EC glial). 3. To study in vitro the cellular and molecular mechanism of EC injury. The hypothesis to be tested is that activation of NO cascade contributes to EC injury under hypoxic/hypoglycemic condition; PMN and glial expression of iNOS accentuate EC injury. The overall objectives of this application are to define further the cellular and molecular mechanisms of post ischemic inflammatory reaction directed at NO cascade and to explore new therapeutic strategies that may reduce the extent of vasogenic brain edema after ischemic stroke.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS028995-09
Application #
2714494
Study Section
Neurology A Study Section (NEUA)
Program Officer
Jacobs, Tom P
Project Start
1990-02-01
Project End
2000-05-31
Budget Start
1998-06-01
Budget End
1999-05-31
Support Year
9
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Washington University
Department
Neurology
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Lin, Teng-nan; Kim, Gyoeng-Moon; Chen, Jean-Ju et al. (2003) Differential regulation of thrombospondin-1 and thrombospondin-2 after focal cerebral ischemia/reperfusion. Stroke 34:177-86
Chen, Shang-Der; Lee, Jin-Moo; Yang, Ding-I et al. (2002) Combination therapy for ischemic stroke: potential of neuroprotectants plus thrombolytics. Am J Cardiovasc Drugs 2:303-13
Yin, Ke-jie; Chen, Shang-Der; Lee, Jin-Moo et al. (2002) ATM gene regulates oxygen-glucose deprivation-induced nuclear factor-kappaB DNA-binding activity and downstream apoptotic cascade in mouse cerebrovascular endothelial cells. Stroke 33:2471-7
Yin, J H; Yang, D I; Chou, H et al. (2001) Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in c6 glioma cells. J Pharmacol Exp Ther 297:308-15
Yan, P; Li, Q; Kim, G M et al. (2001) Cellular localization of tumor necrosis factor-alpha following acute spinal cord injury in adult rats. J Neurotrauma 18:563-8
Xu, J; Chen, S; Ahmed, S H et al. (2001) Amyloid-beta peptides are cytotoxic to oligodendrocytes. J Neurosci 21:RC118
Xu, J; Chen, S; Ku, G et al. (2001) Amyloid beta peptide-induced cerebral endothelial cell death involves mitochondrial dysfunction and caspase activation. J Cereb Blood Flow Metab 21:702-10
Chen, H; Hu, C J; He, Y Y et al. (2001) Reduction and restoration of mitochondrial dna content after focal cerebral ischemia/reperfusion. Stroke 32:2382-7
Kanellopoulos, G K; Xu, X M; Hsu, C Y et al. (2000) White matter injury in spinal cord ischemia: protection by AMPA/kainate glutamate receptor antagonism. Stroke 31:1945-52
Majid, A; He, Y Y; Gidday, J M et al. (2000) Differences in vulnerability to permanent focal cerebral ischemia among 3 common mouse strains. Stroke 31:2707-14

Showing the most recent 10 out of 43 publications